OM1

Healthcare technology for data analytics and insights

Boston, Massachusetts, United States

About OM1

OM1 focuses on enhancing patient outcomes in healthcare through data analytics and artificial intelligence. The company specializes in chronic diseases, utilizing real-world data (RWD) collected from sources like electronic health records and insurance claims to generate real-world evidence (RWE). This evidence helps understand treatment effectiveness in everyday clinical settings. OM1's key product, Aspen, is an automated platform that predicts patient outcomes and provides insights for healthcare decisions. Unlike competitors, OM1 emphasizes the use of AI to identify patients with specific conditions and forecast treatment results, allowing for more tailored care. The company's goal is to improve patient outcomes and support the development of new treatments by providing actionable insights.

Boston, MassachusettsHeadquarters
2015Year Founded
$167.6MTotal Funding
LATE_VCCompany Stage
Data & Analytics, AI & Machine Learning, HealthcareIndustries
51-200Employees

Risks

OM1's dataset expansion may challenge data privacy compliance.
OM1 faces competitive pressure from similar AI healthcare solutions.
New leadership may disrupt current operations or client relationships.

Differentiation

OM1 uses AI to identify patients with specific conditions for precise care.
OM1's Aspen platform predicts patient outcomes for better healthcare decisions.
OM1 combines multiple real-world data sources for deep clinical insights.

Upsides

OM1's AI-driven PhenOM platform is key in personalized medicine.
OM1's new datasets expand real-world evidence in respiratory and ENT diseases.
OM1's Alzheimer's research reflects a trend towards AI for early detection.